Literature DB >> 18082193

Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation.

Jeffrey J Lysiak1, Sang-Kuk Yang, Adam P Klausner, Hwancheol Son, Jeremy B Tuttle, William D Steers.   

Abstract

PURPOSE: Despite techniques to preserve the cavernous nerves during radical prostatectomy erectile dysfunction remains a complication. We determined whether bilateral cavernous nerve resection induces apoptosis in the penis. We also determined whether treatment with the phosphodiesterase-5 inhibitor tadalafil prevents apoptosis as well as the specific mechanisms involved.
MATERIALS AND METHODS: Mice were subjected to cavernous nerve resection or sham surgery. Penises were processed for the identification of apoptotic cells, changes in phosphorylation of several protein kinases and immunolocalization of specific kinases. Mice were also placed on tadalafil or vehicle after cavernous nerve resection and the penises were processed as described. Statistical analysis was performed with the Mann-Whitney U test for comparisons among groups or Student's t test.
RESULTS: An increase in apoptotic cavernous smooth muscle and endothelial cells was evident by 2 weeks, which further increased 4 and 6 weeks after cavernous nerve resection. Apoptosis coincided with an increase in the phosphorylation of c-jun N-terminal kinase and p38 mitogen activated protein kinase. Phospho-c-jun N-terminal kinase was immunolocalized to endothelial and smooth muscle cells. Treatment with tadalafil decreased the number of apoptotic cells and increased the phosphorylation of the 2 survival associated kinases Akt and extracellular signal-regulated kinase 1/2.
CONCLUSIONS: These results provide a rationale for the early use of phosphodiesterase-5 inhibition following radical prostatectomy or extensive pelvic surgery, during which there may be injury to the cavernous nerves, to aid in the return of erectile function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082193     DOI: 10.1016/j.juro.2007.09.021

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats.

Authors:  Johanna L Hannan; Omer Kutlu; Bernard L Stopak; Xiaopu Liu; Fabio Castiglione; Petter Hedlund; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Sex Med       Date:  2014-03-18       Impact factor: 3.802

2.  Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.

Authors:  Thomas J Pugh; Usama Mahmood; David A Swanson; Mark F Munsell; Run Wang; Rajat J Kudchadker; Teresa L Bruno; Steven J Frank
Journal:  Brachytherapy       Date:  2014-09-23       Impact factor: 2.362

3.  Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.

Authors:  Johanna L Hannan; Maarten Albersen; Omer Kutlu; Christian Gratzke; Christian G Stief; Arthur L Burnett; Jeffrey J Lysiak; Petter Hedlund; Trinity J Bivalacqua
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

Review 4.  Tadalafil therapy for erectile dysfunction following prostatectomy.

Authors:  Ateş Kadıoğlu; Mazhar Ortaç; Murat Dinçer; Gerald Brock
Journal:  Ther Adv Urol       Date:  2015-06

5.  The role of hedgehog-interacting protein in maintaining cavernous nerve integrity and adult penile morphology.

Authors:  Nicholas L Angeloni; Christopher W Bond; Diana Monsivais; Yi Tang; Carol A Podlasek
Journal:  J Sex Med       Date:  2009-06-09       Impact factor: 3.802

Review 6.  Sonic hedgehog, apoptosis, and the penis.

Authors:  Carol A Podlasek
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 7.  The role and structure of a postradical prostatectomy penile rehabilitation program.

Authors:  John P Mulhall
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

8.  Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.

Authors:  Monica G Ferrini; Istvan Kovanecz; Sandra Sanchez; Chiome Umeh; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2008-12-02       Impact factor: 3.802

Review 9.  Phosphodiesterases as therapeutic targets for Alzheimer's disease.

Authors:  Ana García-Osta; Mar Cuadrado-Tejedor; Carolina García-Barroso; Julen Oyarzábal; Rafael Franco
Journal:  ACS Chem Neurosci       Date:  2012-10-01       Impact factor: 4.418

10.  Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.

Authors:  Min Chul Cho; Junghoon Lee; Juhyun Park; Soo Woong Kim
Journal:  World J Mens Health       Date:  2020-07-09       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.